R. Fijn

575 total citations
17 papers, 442 citations indexed

About

R. Fijn is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, R. Fijn has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 6 papers in Economics and Econometrics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in R. Fijn's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). R. Fijn is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). R. Fijn collaborates with scholars based in Netherlands, Spain and New Zealand. R. Fijn's co-authors include J. R. B. J. Brouwers, Patricia M. L. A. van den Bemt, Toine C. G. Egberts, Peter H. J. van der Voort, C. J. De Blaey, L T W de Jong-van den Berg, Maarten J. Postma, Eric N. van Roon, Lolkje T.W. de Jong‐van den Berg and A.W. Lenderink and has published in prestigious journals such as Critical Care Medicine, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

R. Fijn

15 papers receiving 416 citations

Peers

R. Fijn

EMS

HIM

PPCH

SURGE

Allen J. Vaida United States

Michael Peters United States

Rowena McArtney United Kingdom

Nicole R. Hartnell Canada

Micheline Jacquet France

Carla Meyer‐Massetti Switzerland

Judy L. Smetzer United States

Anne Bobb United States

Johanna Ulfvarson Sweden

James R. Guidry United States

Allen J. Vaida United States

R. Fijn

173 ×0.7

157 ×0.7

EMS

95 ×1.3

HIM

64 ×0.9

PPCH

53 ×0.8

SURGE

Citations per year, relative to R. Fijn R. Fijn (= 1×) peers Allen J. Vaida

Countries citing papers authored by R. Fijn

Since Specialization

Citations

This map shows the geographic impact of R. Fijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fijn more than expected).

Fields of papers citing papers by R. Fijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fijn. The network helps show where R. Fijn may publish in the future.

Co-authorship network of co-authors of R. Fijn

This figure shows the co-authorship network connecting the top 25 collaborators of R. Fijn. A scholar is included among the top collaborators of R. Fijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Fijn. R. Fijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Fijn, R., et al.. (2024). Hydroxychloroquine as a Promising Therapy for Systemic IgG4-Related Disease: A Case Report. American Journal of Case Reports. 25. e944731–e944731.

Fijn, R., et al.. (2003). Prevention of heterotopic ossification after total hip replacement with NSAIDs.. Pharmacy World & Science. 25(4). 138–145. 48 indexed citations

Fijn, R., et al.. (2002). Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects Part II: the use of ethics. Pharmacoepidemiology and Drug Safety. 11(7). 617–620. 1 indexed citations

Fijn, R., et al.. (2002). Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees?. Pharmacoepidemiology and Drug Safety. 11(3). 247–252. 7 indexed citations

Fijn, R., et al.. (2002). Hospital prescribing errors: epidemiological assessment of predictors. British Journal of Clinical Pharmacology. 53(3). 326–331. 86 indexed citations

Bemt, Patricia M. L. A. van den, et al.. (2002). Frequency and determinants of drug administration errors in the intensive care unit*. Critical Care Medicine. 30(4). 846–850. 166 indexed citations

Bemt, Patricia M. L. A. van den, et al.. (2002). Cost-Benefit Analysis of the Detection of Prescribing Errors by Hospital Pharmacy Staff. Drug Safety. 25(2). 135–143. 52 indexed citations

Fijn, R., et al.. (2002). Multicentre evaluation of prescribing concurrence with anti‐infective guidelines: epidemiological assessment of indicators. Pharmacoepidemiology and Drug Safety. 11(5). 361–372. 18 indexed citations

Fijn, R., et al.. (2002). Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects Part I: An explorative overview. Pharmacoepidemiology and Drug Safety. 11(6). 523–527. 3 indexed citations

10.

Fijn, R., et al.. (2001). Assessment of indicators for hospital drug formulary non-adherence. European Journal of Clinical Pharmacology. 57(9). 677–684. 12 indexed citations

11.

Fijn, R., et al.. (2000). Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national guidelines. British Journal of Clinical Pharmacology. 254–264. 3 indexed citations

12.

Fijn, R., et al.. (2000). Dutch Hospital Drug Formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines. British Journal of Clinical Pharmacology. 49(3). 254–263. 7 indexed citations

13.

Fijn, R., et al.. (2000). Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines.. Pharmacy World & Science. 22(4). 152–158. 5 indexed citations

14.

Fijn, R., et al.. (2000). Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines. European Journal of Clinical Pharmacology. 56(9-10). 739–746. 3 indexed citations

15.

Fijn, R., et al.. (1999). Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.. Pharmacy World & Science. 21(2). 74–79. 22 indexed citations

16.

Fijn, R., et al.. (1999). Cross-sectoral pharmacotherapeutic coherence in the Netherlands. International Journal of Pharmacy Practice. 7(3). 159–166. 3 indexed citations

17.

Fijn, R., et al.. (1999). The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.. Pharmacy World & Science. 21(3). 120–126. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact